Bionano Genomics (BNGO) Long-Term Debt Repayments (2018 - 2025)

Bionano Genomics' Long-Term Debt Repayments history runs 6 years deep, the most recent figure standing at $1.9 million for Q3 2025.

• In Q3 2025, Long-Term Debt Repayments rose 20.5% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $3.4 million (down 48.08% YoY), while the FY2025 annual figure was $4.9 million, down 2.5% from the prior year.
• Long-Term Debt Repayments came in at $1.9 million for Q3 2025 at Bionano Genomics, up from $1.5 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $17.0 million in Q2 2021 to a low of -$2.0 million in Q4 2021.
• A 3-year average of $3.1 million and a median of $1.5 million in 2024 frame the typical range for Long-Term Debt Repayments.
• Across the five-year window, Long-Term Debt Repayments surged 486.55% in 2021 and grew 3.88% in 2025, its largest moves.
• Bionano Genomics' Long-Term Debt Repayments stood at -$2.0 million in 2021, then surged by 199.5% to $2.0 million in 2024, then slipped by 6.25% to $1.9 million in 2025.
• According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $1.9 million, $1.5 million, and $1.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison